Articles from this edition:
Latest articles
Novartis’ Kisqali® shows overall survival benefit in advanced breast cancer
Novartis has announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, reinforcing the overall survival (OS) benefit of Kisqali®...
Pf Webinar: Adopting Agile in pharma for more effective cross-functional marketing teamwork
Pf is proud to announce the second instalment of the FREE webinar series with Triducive. This webinar focuses on Agile and how it can...
New Patient Recruitment Centres for late-phase clinical research
NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...
Popular articles
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Novartis’ Kisqali® shows overall survival benefit in advanced breast cancer
Novartis has announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, reinforcing the overall survival (OS) benefit of Kisqali®...
Digital transformation in the NHS
A new report by the National Audit Office (NAO) on digital transformation in the NHS has found that recent investment in digital transformation has...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...